Journal of Multidisciplinary Applied Natural Science
Periódico de Acesso Aberto
Scopus CiteScore 2025
2.1
Calculated on 05 May, 2025
SJR 2025
0.25
Powered by scimagojr.com
Periódico de Acesso Aberto
2.1
Calculated on 05 May, 2025
0.25
Powered by scimagojr.com
https://doi.org/10.47352/jmans.2774-3047.472
Andi Ernawati
Iman Rusmana
Aris Tri Wahyudi
Sri Murtini
Sri Budiarti
The wound's microbiome in patients with diabetes plays a vital role for developing of diabetic ulcers. Molecular sequencing technologies have enhanced our understanding of microbial diversity in diabetic wounds, making microbiome profiling analysis essential for supporting effective clinical management. A metagenomic approach enables the more accurate identification of pathogenic bacteria to support rational antibiotic use and the development of more targeted therapies. This study aimed to identify the bacterial diversity in diabetic ulcers before and after antibiotic therapy using a metagenomic approach to analyze changes in the microbiome profile and detect potentially antibiotic-resistant pathogenic bacteria. Wound swabs from each patient were genomically extracted for metagenomic analysis using nanopore sequencing. The samples from individuals administered antibiotics were coded 4, 7AB, and 8, whereas the samples from patients not administered antibiotics were coded 11. Limitations of this study include its relatively small sample size (n = 4). This study shows that the species with the highest abundance in sample 11 was Acinetobacter junii, in sample 4 was Proteus mirabilis, in sample 7AB were Alcaligenes faecalis and Pseudomonas aeruginosa, and in sample 8 was Acinetobacter baumannii. Both groups who did not receive antibiotic treatment and those who received antibiotic therapy showed the presence of diverse microorganisms, including potentially pathogenic bacteria. Future treatment regimens should be based on the type of bacterial infection in wounds of diabetic patients.
[1] B. L. Price, R. Morley, F. L. Bowling, A. M. Lovering, and C. B. Dobson. (2020). "Susceptibility of Monomicrobial or Polymicrobial Biofilms Derived from Infected Diabetic Foot Ulcers to Topical or Systemic Antibiotics In Vitro". PLoS ONE. 15 (2): 1-14. 10.1371/journal.pone.0228704.
DOI: https://doi.org/10.1371/journal.pone.0228704[2] N. Safitri, D. Kusumaningrum, A. D. Saputri, and H. Kusuma. (2020). "Karakteristik Diabetic Foot Ulcer (DFU) pada Individu dengan Diabetes Mellitus (DM): Studi Deskripsi Cross-Sectional". Journal of Holistic Nursing Science. 7 (2): 88-98. 10.31603/nursing.v7i2.3074.
DOI: https://doi.org/10.31603/nursing.v7i2.3074[3] P. Zhang, J. Lu, Y. Jing, S. Tang, D. Zhu, and Y. Bi. (2017). "Global Epidemiology of Diabetic Foot Ulceration: A Systematic Review and Meta-Analysis". Annals of Medicine. 49 (2): 106-116. 10.1080/07853890.2016.1231932.
DOI: https://doi.org/10.1080/07853890.2016.1231932[4] K. McDermott, M. Fang, A. J. M. Boulton, E. Selvin, and C. W. Hicks. (2023). "Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers". Diabetes Care. 46 (1): 208-221. 10.2337/dci22-0043.
DOI: https://doi.org/10.2337/dci22-0043[5] E. Yunir, D. L. Tahapary, T. J. E. Tarigan, D. S. Harbuwono, Y. D. Oktavianda, M. Kristanti, E. Iswati, A. Sarumpaet, and P. Soewondo. (2021). "Non-Vascular Contributing Factors of Diabetic Foot Ulcer Severity in National Referral Hospital of Indonesia". Journal of Diabetes and Metabolic Disorders. 20 (1): 805-813. 10.1007/s40200-021-00827-x.
DOI: https://doi.org/10.1007/s40200-021-00827-x[6] Y. Sari, A. S. Upoyo, A. Isworo, A. Taufik, A. Sumeru, D. Anandari, and E. Sutrisna. (2020). "Foot Self-Care Behavior and Its Predictors in Diabetic Patients in Indonesia". BMC Research Notes. 13 (1): 4-9. 10.1186/s13104-020-4903-y.
DOI: https://doi.org/10.1186/s13104-020-4903-y[7] S. Dörr, A. K. Holland-Letz, G. Weisser, A. Chatzitomaris, and R. Lobmann. (2023). "Bacterial Diversity, Antibiotic Resistance, and the Risk of Lower Limb Amputation in Younger and Older Individuals with Diabetic Foot Infection". International Journal of Lower Extremity Wounds. 22 (1): 63-71. 10.1177/1534734621992290.
DOI: https://doi.org/10.1177/1534734621992290[8] W. F. Mohamed, A. A. Askora, M. M. H. Mahdy, E. A. El-Hussieny, and H. M. Abu-Shady. (2022). "Isolation and Characterization of Bacteriophages Active Against Pseudomonas aeruginosa Strains Isolated from Diabetic Foot Infections". Archives of Razi Institute. 77 (6): 2187-2200. 10.22092/ARI.2022.359032.2357.
[9] A. Boulton, D. Armstrong, M. Hardman, M. Malone, J. Embil, C. Attinger, B. Lipsky, J. Aragon-Sanchez, H. Kwong, G. Schultz, and R. Kirsner. (2020). "Diagnosis and Management of Diabetic Foot Infections". ADA Clinical Compendia. 2020 (1): 1-24. 10.2337/db2020-01.
DOI: https://doi.org/10.2337/db2020-01[10] Z. Idris, Palisoa, and A. Ernawati. (2020). "Pola Resistensi Bakteri pada Ulkus Diabetik". Prosiding Seminar Nasional Biologi di Era Pandemi COVID-19. 1 : 140-143.
[11] N. Holman, A. C. Yelland, B. Young, J. Valabhji, W. Jeffcoate, and F. Game. (2024). "Mortality Rates in People Presenting with a New Diabetes-Related Foot Ulcer: A Cohort Study with Implications for Management". Diabetologia. 67 (12): 2691-2701. 10.1007/s00125-024-06262-w.
DOI: https://doi.org/10.1007/s00125-024-06262-w[12] M. R. Yani, D. I. N. Pratiwi, R. Rahmiati, N. Muthmainah, and A. Yasmina. (2021). "Antibiotics Susceptibility Pattern in Diabetic Ulcer Patients". Indonesian Journal of Clinical Pathology and Medical Laboratory. 27 (2): 205-211. 10.24293/ijcpml.v27i2.1652.
DOI: https://doi.org/10.24293/ijcpml.v27i2.1652[13] A. M. Pinto, M. A. Cerqueira, M. Bañobre-López, L. M. Pastrana, and S. Sillankorva. (2020). "Bacteriophages for Chronic Wound Treatment: From Traditional to Novel Delivery Systems". Viruses. 12 (2): 1-29. 10.3390/v12020235.
DOI: https://doi.org/10.3390/v12020235[14] A. Ernawati, I. Rusmana, A. Wahyudi, S. Murtini, and S. Budiarti. (2025). "Hemolysin-Based Screening of Bacterial Pathogens in Patients with Diabetic Ulcers". 10.1088/1755-1315/1550/1/012026.
DOI: https://doi.org/10.1088/1755-1315/1550/1/012026[15] A. Ernawati, I. Rusmana, A. T. Wahyudi, S. Murtini, and S. Budiarti. (2026). "Phenotypic and Genotypic Characterization of Bacteria from Diabetic Ulcers: Insights into Resistance and Biofilm Formation". Journal of Multidisciplinary Applied Natural Science. 6 (2): 604-622. 10.47352/jmans.2774-3047.348.
DOI: https://doi.org/10.47352/jmans.2774-3047.348[16] H. Xie, Z. Chen, G. Wu, P. Wei, T. Gong, and S. Chen. (2025). "Application of Metagenomic Next-Generation Sequencing (mNGS) to Describe the Microbial Characteristics of Diabetic Foot Ulcers at a Tertiary Medical Center in South China". BMC Endocrine Disorders. 25 (1): 1-10. 10.1186/s12902-025-01837-z.
DOI: https://doi.org/10.1186/s12902-025-01837-z[17] M. Morsli, F. Salipante, C. Magnan, C. Dunyach-Remy, and A. Sotto. (2024). "Direct Metagenomics Investigation of Non-Surgical Hard-to-Heal Wounds: A Review". Annals of Clinical Microbiology and Antimicrobials. 23 : 1-17. 10.1186/s12941-024-00698-z.
DOI: https://doi.org/10.1186/s12941-024-00698-z[18] H. Mudrik-Zohar, S. Carasso, T. Gefen, A. Zalmanovich, M. Katzir, Y. Cohen, Y. Paitan, N. Geva-Zatorsky, and M. Chowers. (2022). "Microbiome Characterization of Infected Diabetic Foot Ulcers in Association with Clinical Outcomes: Traditional Cultures Versus Molecular Sequencing Methods". Frontiers in Cellular and Infection Microbiology. 12 : 1-13. 10.3389/fcimb.2022.836699.
DOI: https://doi.org/10.3389/fcimb.2022.836699[19] C. Y. Chiu and S. A. Miller. (2019). "Clinical Metagenomics". Nature Reviews Genetics. 20 (6): 341-355. 10.1038/s41576-019-0113-7.
DOI: https://doi.org/10.1038/s41576-019-0113-7[20] R. R. Wick, L. M. Judd, and K. E. Holt. (2019). "Performance of Neural Network Basecalling Tools for Oxford Nanopore Sequencing". Genome Biology. 20 (1): 1-10. 10.1186/s13059-019-1727-y.
DOI: https://doi.org/10.1186/s13059-019-1727-y[21] W. De Coster, S. D'Hert, D. T. Schultz, M. Cruts, and C. Van Broeckhoven. (2018). "NanoPack: Visualizing and Processing Long-Read Sequencing Data". Bioinformatics. 34 (15): 2666-2669. 10.1093/bioinformatics/bty149.
DOI: https://doi.org/10.1093/bioinformatics/bty149[22] A. B. Nygaard, H. S. Tunsjø, R. Meisal, and C. Charnock. (2020). "A Preliminary Study on the Potential of Nanopore MinION and Illumina MiSeq 16S rRNA Gene Sequencing to Characterize Building-Dust Microbiomes". Scientific Reports. 10 (1): 3209. 10.1038/s41598-020-59771-0.
DOI: https://doi.org/10.1038/s41598-020-59771-0[23] D. Kim, L. Song, F. P. Breitwieser, and S. L. Salzberg. (2016). "Centrifuge: Rapid and Accurate Classification of Metagenomic Sequences". Genome Research. 26 (12): 1721-1729. 10.1101/gr.210641.116.
DOI: https://doi.org/10.1101/gr.210641.116[24] J. S. Johnson, D. J. Spakowicz, B. Hong, L. M. Petersen, P. Demkowicz, L. Chen, S. R. Leopold, B. M. Hanson, H. O. Agresta, M. Gerstein, E. Sodergren, and G. M. Weinstock. (2019). "Evaluation of 16S rRNA Gene Sequencing for Species and Strain-Level Microbiome Analysis". Nature Communications. 10 : 1-11. 10.1038/s41467-019-13036-1.
DOI: https://doi.org/10.1038/s41467-019-13036-1[25] Y. Matsuo, S. Komiya, Y. Yasumizu, Y. Yasuoka, K. Mizushima, T. Takagi, K. Kryukov, A. Fukuda, Y. Morimoto, Y. Naito, H. Okada, H. Bono, S. Nakagawa, and K. Hirota. (2021). "Full-Length 16S rRNA Gene Amplicon Analysis of Human Gut Microbiota Using MinION Nanopore Sequencing Confers Species-Level Resolution". BMC Microbiology. 21 : 1-13. 10.1186/s12866-021-02094-5.
DOI: https://doi.org/10.1186/s12866-021-02094-5[26] S. O. Oyibo, E. B. Jude, I. Tarawneh, H. C. Nguyen, L. B. Harkless, and A. J. M. Boulton. (2001). "A Comparison of Two Diabetic Foot Ulcer Classification Systems". Diabetes Care. 24 (1): 84-88. 10.2337/diacare.24.1.84.
DOI: https://doi.org/10.2337/diacare.24.1.84[27] M. Tomic-Canic, J. L. Burgess, K. E. O'Neill, N. Strbo, and I. Pastar. (2020). "Skin Microbiota and Its Interplay with Wound Healing". American Journal of Clinical Dermatology. 21 (S1): 36-43. 10.1007/s40257-020-00536-w.
DOI: https://doi.org/10.1007/s40257-020-00536-w[28] A. Alhubail, M. Sewify, G. Messenger, R. Masoetsa, I. Hussain, S. Nair, and A. Tiss. (2020). "Microbiological Profile of Diabetic Foot Ulcers in Kuwait". PLoS ONE. 15 (12): 1-15. 10.1371/journal.pone.0244306.
DOI: https://doi.org/10.1371/journal.pone.0244306[29] K. B. D. Travis and J. Bradbury. (2023). "Toward Non-Invasive Collection Methods for Sampling the Microbiome of Diabetic Foot Ulcers". International Wound Journal. 20 (9): 1-7. 10.1111/iwj.14267.
DOI: https://doi.org/10.1111/iwj.14267[30] E. Narulita, V. I. N. Cahyati, R. A. Febrianti, and M. Iqbal. (2023). "Potential Bacteriophages to Overcome Bacterial Infection of Alcaligenes faecalis in Diabetic Ulcer". Pediatric Endocrinology, Diabetes and Metabolism. 29 (2): 61-66. 10.5114/pedm.2023.125363.
DOI: https://doi.org/10.5114/pedm.2023.125363[31] A. Ernawati, Raodah, and Idris. (2019). "Identifikasi Bakteri pada Pasien Penderita Luka Diabetes Melitus di Rumah Sakit Ibnu Sina Makassar". Prosiding Seminar Nasional Biodiversitas Indonesia. 15-18.
[32] R. D. Wolcott, J. D. Hanson, E. J. Rees, L. D. Koenig, C. D. Phillips, R. A. Wolcott, S. B. Cox, and J. S. White. (2016). "Analysis of the Chronic Wound Microbiota of 2,963 Patients by 16S rDNA Pyrosequencing". Wound Repair and Regeneration. 24 (1): 163-174. 10.1111/wrr.12370.
DOI: https://doi.org/10.1111/wrr.12370[33] A. Jnana, V. Muthuraman, V. K. Varghese, S. Chakrabarty, T. S. Murali, L. Ramachandra, K. R. Shenoy, G. S. Rodrigues, S. S. Prasad, D. Dendukuri, A. Morschhauser, J. Nestler, H. Peter, F. F. Bier, and K. Satyamoorthy. (2020). "Microbial Community Distribution and Core Microbiome in Successive Wound Grades of Individuals with Diabetic Foot Ulcers". Applied and Environmental Microbiology. 86 (6): 1-14. 10.1128/AEM.02608-19.
DOI: https://doi.org/10.1128/AEM.02608-19[34] Y. Huang, Z. Xiao, Y. Cao, F. Gao, Y. Fu, M. Zou, X. Luo, Y. Jiang, and Y. Xue. (2022). "Rapid Microbiological Diagnosis Based on 16S rRNA Gene Sequencing: A Comparison of Bacterial Composition in Diabetic Foot Infections and Contralateral Intact Skin". Frontiers in Microbiology. 13 : 1-11. 10.3389/fmicb.2022.1021955.
DOI: https://doi.org/10.3389/fmicb.2022.1021955[35] G. Orazi and G. A. O'Toole. (2020). ""It Takes a Village": Mechanisms Underlying Antimicrobial Recalcitrance of Polymicrobial Biofilms". Journal of Bacteriology. 202 (1). 10.1128/JB.00530-19.
DOI: https://doi.org/10.1128/JB.00530-19[36] D. Ruben, A. Sanya, D. Onésime, G. Vizzarro, and N. Jacquier. (2023). "Recent Advances in Therapeutic Targets Identification and Development of Treatment Strategies Towards Pseudomonas aeruginosa Infections". BMC Microbiology. 23 : 1-18. 10.1186/s12866-023-02832-x.
DOI: https://doi.org/10.1186/s12866-023-02832-x[37] S. A. Sheweita, A. A. Amara, H. Gamal, A. A. Ghazy, A. Hussein, and M. Bahey-El-Din. (2022). "Bacterial Ghosts of Pseudomonas aeruginosa as a Promising Candidate Vaccine and Its Application in Diabetic Rats". Vaccines. 10 (6). 10.3390/vaccines10060910.
DOI: https://doi.org/10.3390/vaccines10060910[38] F. Villa, H. Marchandin, J. Lavigne, S. Schuldiner, N. Cellier, A. Sotto, and P. Loubet. (2024). "Epidemiology, Virulence, and Management". Clinical Microbiology Reviews. 37 (3): 1-26. 10.1128/CMR.00143-23.
DOI: https://doi.org/10.1128/cmr.00143-23[39] A. Atlaw, H. B. Kebede, A. A. Abdela, and Y. Woldeamanuel. (2022). "Bacterial Isolates from Diabetic Foot Ulcers and Their Antimicrobial Resistance Profile from Selected Hospitals in Addis Ababa, Ethiopia". Frontiers in Endocrinology. 13 : 1-10. 10.3389/fendo.2022.987487.
DOI: https://doi.org/10.3389/fendo.2022.987487[40] T. Lin, Q. Li, D. Jin, W. Liu, C. Tang, and X. Zhang. (2021). "Investigation of Virulence Genes of Staphylococcus aureus Isolated from Sterile Body Fluid Samples and Their Correlation with Clinical Symptoms and Outcomes". Canadian Journal of Infectious Diseases and Medical Microbiology. 2021. 10.1155/2021/5354747.
DOI: https://doi.org/10.1155/2021/5354747[41] B. Löffler, M. Hussain, M. Grundmeier, M. Brück, D. Holzinger, G. Varga, J. Roth, B. C. Kahl, R. A. Proctor, and G. Peters. (2010). "Staphylococcus aureus Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils". PLoS Pathogens. 6 (1). 10.1371/journal.ppat.1000715.
DOI: https://doi.org/10.1371/journal.ppat.1000715[42] K. Shettigar and T. S. Murali. (2020). "Virulence Factors and Clonal Diversity of Staphylococcus aureus in Colonization and Wound Infection with Emphasis on Diabetic Foot Infection". European Journal of Clinical Microbiology and Infectious Diseases. 39 (12): 2235-2246. 10.1007/s10096-020-03984-8.
DOI: https://doi.org/10.1007/s10096-020-03984-8[43] F. Du, J. Ma, H. Gong, R. Bista, P. Zha, Y. Ren, Y. Gao, D. Chen, X. Ran, and C. Wang. (2022). "Microbial Infection and Antibiotic Susceptibility of Diabetic Foot Ulcer in China: Literature Review". Frontiers in Endocrinology. 13 : 1-9. 10.3389/fendo.2022.881659.
DOI: https://doi.org/10.3389/fendo.2022.881659[44] S. Maity, N. Leton, N. Nayak, A. Jha, N. Anand, K. Thompson, D. Boothe, A. Cromer, Y. Garcia, A. Al-Islam, and S. Nauhria. (2024). "A Systematic Review of Diabetic Foot Infections: Pathogenesis, Diagnosis, and Management Strategies". Frontiers in Clinical Diabetes and Healthcare. 5 : 1-14. 10.3389/fcdhc.2024.1393309.
DOI: https://doi.org/10.3389/fcdhc.2024.1393309[45] P. Baral, N. Afnan, M. A. Zahra, B. Akter, S. R. Prapti, M. M. Hossan, and F. K. M. Haque. (2024). "Bacteriological Analysis and Antibiotic Resistance in Patients with Diabetic Foot Ulcers in Dhaka". PLoS ONE. 19 (5): 1-23. 10.1371/journal.pone.0301767.
DOI: https://doi.org/10.1371/journal.pone.0301767[46] O. H. Ajigbewu, F. M. Adeyemi, A. A. Wahab, O. O. Oyedara, N. A. Yusuf-Omoloye, and F. A. Ajigbewu. (2025). "Occurrence of Extremely Drug-Resistant Klebsiella and Multidrug-Resistant Enterobacter Species in Chronic Wound Patients". Microbes and Infectious Diseases. 6 (1): 342-354. 10.21608/mid.2024.259210.1740.
DOI: https://doi.org/10.21608/mid.2024.259210.1740[47] R. Shivani, C. Durai Singh, S. Kumar, and R. Muthusamy. (2024). "Prevalence and Antibiotic Resistance of Klebsiella pneumoniae in Diabetic Foot Ulcer". Cureus. 16 (8). 10.7759/cureus.67824.
DOI: https://doi.org/10.7759/cureus.67824[48] A. M. H. Al-Kamoosi and I. H. Al-Azawi. (2021). "Detection of Capsular Polysaccharide Virulence Genes rmpA and magA of Klebsiella pneumoniae Isolates from Diabetic Foot Ulcer Patients in Najaf Governorate, Iraq". Indian Journal of Forensic Medicine and Toxicology. 15 (2): 3061-3067. 10.37506/ijfmt.v15i2.14841.
DOI: https://doi.org/10.37506/ijfmt.v15i2.14841[49] S. Mohammed and N. Abdulla. (2023). "Studying Several Virulence Factors Phenotypically and Genetically to Isolate Klebsiella pneumoniae from Diabetic Patients". Egyptian Academic Journal of Biological Sciences, Section C: Physiology and Molecular Biology. 15 (2): 59-65. 10.21608/eajbsc.2023.309053.
DOI: https://doi.org/10.21608/eajbsc.2023.309053[50] C. Shao, L. Xin, P. Mi, M. Jiang, and H. Wu. (2022). "Phenotypic and Molecular Characterization of K54-ST29 Hypervirulent Klebsiella pneumoniae Causing Multi-System Infection in a Patient with Diabetes". Frontiers in Microbiology. 13. 10.3389/fmicb.2022.872140.
DOI: https://doi.org/10.3389/fmicb.2022.872140[51] R. Morena, H. L. Morrone, V. Olivadese, S. Palma, F. Serapide, and A. Russo. (2026). "New Insights into Acinetobacter baumannii Pathogenesis and Therapeutic Implications". Pathogens. 15 (4): 1-23. 10.3390/pathogens15040391.
DOI: https://doi.org/10.3390/pathogens15040391[52] A. Abo-Zed, M. Yassin, and T. Phan. (2020). "Acinetobacter junii as a Rare Pathogen of Urinary Tract Infection". Urology Case Reports. 32 101209. 10.1016/j.eucr.2020.101209.
DOI: https://doi.org/10.1016/j.eucr.2020.101209[53] M. P. Ryan and J. T. Pembroke. (2026). "Delftia spp. as Opportunistic Pathogens: A Narrative Review". New Microbes and New Infections. 70 : 101705. 10.1016/j.nmni.2026.101705.
DOI: https://doi.org/10.1016/j.nmni.2026.101705[54] L. Zhang, X. Zhang, H. Bai, T. Li, Z. Zhang, X. Zong, X. Shang, Z. Liu, and L. Fan. (2024). "Characterization and Genome Analysis of the Delftia lacustris Strain LzhVag01 Isolated from Vaginal Discharge". Current Microbiology. 81 (8): 1-11. 10.1007/s00284-024-03758-x.
DOI: https://doi.org/10.1007/s00284-024-03758-x[55] B. K. Behera, S. N. Parida, V. Kumar, H. S. Swain, P. K. Parida, K. Bisai, S. Dhar, and B. K. Das. (2023). "Aeromonas veronii Is a Lethal Pathogen Isolated from the Gut of Infected Labeo rohita: Molecular Insight to Understand the Bacterial Virulence and Its Induced Host Immunity". Pathogens. 12 (4): 1-18. 10.3390/pathogens12040598.
DOI: https://doi.org/10.3390/pathogens12040598[56] E. Rajni, S. Kataria, M. K. Sarna, and V. K. Garg. (2023). "A Case of Bacteremia by Achromobacter xylosoxidans in an Immunocompromised Host and Review of the Literature". Archives of Medicine and Health Sciences. 11 (1): 141-144. 10.4103/amhs.amhs_222_22.
DOI: https://doi.org/10.4103/amhs.amhs_222_22[57] M. Rus, M. Licker, C. Musuroi, E. Seclaman, D. Muntean, N. Cirlea, A. Tamas, S. Vulpie, F. G. Horhat, and L. Baditoiu. (2020). "Distribution of NDM-1 Carbapenemase-Producing Proteeae Strains on High-Risk Hospital Wards". Infection and Drug Resistance. 13 : 4751-4761. 10.2147/IDR.S280977.
DOI: https://doi.org/10.2147/IDR.S280977[58] M. Rus, M. Licker, C. Musuroi, D. Muntean, S. Vulpie, O. Magiar, T. Sorescu, S. I. Musuroi, A. Voinescu, and L. M. Baditoiu. (2022). "Association of Proteus mirabilis and Providencia stuartii Infections with Diabetes". Medicina. 58. 10.3390/medicina58020271.
DOI: https://doi.org/10.3390/medicina58020271[59] M. Eltaweel and H. S. Said. (2024). "Emergence of Extensive Drug Resistance and High Prevalence of Multidrug Resistance Among Clinical Proteus mirabilis Isolates in Egypt". Annals of Clinical Microbiology and Antimicrobials. 23 : 1-11. 10.1186/s12941-024-00705-3.
DOI: https://doi.org/10.1186/s12941-024-00705-3[60] F. P. Ndakidemi and A. Mzula. (2023). "Antimicrobial Susceptibility Patterns and Molecular Phylogenetics of Proteus mirabilis Isolated from Domestic Rats: An Environmental Driver to Antimicrobial Resistance in Public Health in Arusha, Tanzania". Global Journal of Microbiology. 3 (1): 13-23. 10.51585/gjm.2023.1.0022.
DOI: https://doi.org/10.51585/gjm.2023.1.0022[61] Y. Li, M. Yin, C. Fang, Y. Fu, and X. Dai. (2023). "Genetic Analysis of Resistance and Virulence Characteristics of Clinical Multidrug-Resistant Proteus mirabilis Isolates". Frontiers in Cellular and Infection Microbiology. 13 : 1-11. 10.3389/fcimb.2023.1229194.
DOI: https://doi.org/10.3389/fcimb.2023.1229194[62] Z. Chen, J. Wang, K. Wang, and F. An. (2025). "Multidrug-Resistant Proteus mirabilis in a Critically Endangered Malayan Pangolin: Clinical and Genomic Insights". Frontiers in Veterinary Science. 12. 10.3389/fvets.2025.1552499.
DOI: https://doi.org/10.3389/fvets.2025.1552499[63] M. S. Sanches, C. R. Da Silva, L. C. Silva, V. H. Montini, M. G. L. Barboza, G. H. M. Guidone, B. H. D. De Oliva, E. K. Nishio, L. C. F. Galhardi, E. C. Vespero, M. C. L. Nogueira, and S. P. D. Rocha. (2021). "Proteus mirabilis from Community-Acquired Urinary Tract Infections Shares Genetic Similarity and Virulence Factors with Isolates from Chicken, Beef and Pork Meat". Microbial Pathogenesis. 158 : 105098. 10.1016/j.micpath.2021.105098.
DOI: https://doi.org/10.1016/j.micpath.2021.105098[64] H. J. Busse. (2016). "Review of the Taxonomy of the Genus Arthrobacter, Emendation of the Genus Arthrobacter sensu lato, Proposal to Reclassify Selected Species of the Genus Arthrobacter in the Novel Genera Glutamicibacter gen. nov., Paeniglutamicibacter gen. nov., Pseudoglutamicibacter gen. nov., Paenarthrobacter gen. nov., and Pseudarthrobacter gen. nov". International Journal of Systematic and Evolutionary Microbiology. 66 (1): 9-37. 10.1099/ijsem.0.000702.
DOI: https://doi.org/10.1099/ijsem.0.000702[65] P. Ioannou, S. Maraki, E. Velivasakis, and D. P. Kofteridis. (2024). "Pseudoglutamicibacter cumminsii in Polymicrobial Osteomyelitis of the Tibia in a Female Patient: A Case Report". GERMS. 14 (1): 95-100. 10.18683/germs.2024.1421.
DOI: https://doi.org/10.18683/germs.2024.1421[66] L. C. Blanco, C. Gómez-Camarasa, M. I. López, N. C. Porcuna, and L. L. Rojas-García. (2022). "Unusual Isolation of Pseudoglutamicibacter cumminsii in Urine Culture". Revista Española de Quimioterapia. 35 (1): 95-96. 10.37201/req/088.2021.
DOI: https://doi.org/10.37201/req/088.2021[67] M. Adabi, S. Hamid, and S. Bakhtiari. (2022). "The First Study of Investigation of Clinical Isolates of Alcaligenes xylosoxidans and Alcaligenes faecalis by Phenotypic and Genetic Methods in Iran". Iranian Journal of Medical Microbiology. 16 (2): 148-154. 10.30699/ijmm.16.2.148.
DOI: https://doi.org/10.30699/ijmm.16.2.148[68] K. A. Glen and I. L. Lamont. (2024). "Characterization of Acquired β-Lactamases in Pseudomonas aeruginosa and Quantification of Their Contributions to Resistance". Microbiology Spectrum. 12 (10): 1-16. 10.1128/spectrum.00694-24.
DOI: https://doi.org/10.1128/spectrum.00694-24[69] E. A. Mohamed, M. M. Raafat, R. S. Mohamed, A. Emad, and E. Ali. (2023). "Acinetobacter baumannii Biofilm and Its Potential Therapeutic Targets". Future Journal of Pharmaceutical Sciences. 9 : 1-20. 10.1186/s43094-023-00525-w.
DOI: https://doi.org/10.1186/s43094-023-00525-w[70] A. M. Ghareeb, M. M. Raafat, N. S. Bazan, and R. Samir. (2024). "Carbapenem-Resistant Acinetobacter baumannii Infections Among Diabetic and Non-Diabetic Patients and Possible Effective Combination Treatments". Future Journal of Pharmaceutical Sciences. 10 : 1-16. 10.1186/s43094-024-00661-x.
DOI: https://doi.org/10.1186/s43094-024-00661-x[71] Z. Asmare, E. Tamrat, M. Erkihun, K. Endalamaw, D. Alelign, and M. Getie. (2025). "Antimicrobial Resistance Pattern of Acinetobacter baumannii Clinical Isolates in Ethiopia: A Systematic Review and Meta-Analysis". BMC Infectious Diseases. 25 : 1-13. 10.1186/s12879-025-10923-5.
DOI: https://doi.org/10.1186/s12879-025-10923-5[72] C. A. Moubareck and D. H. Halat. (2020). "Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen". Antibiotics. 9 (3): 1-29. 10.3390/antibiotics9030119.
DOI: https://doi.org/10.3390/antibiotics9030119[73] G. M. Traglia, F. Pasteran, S. Moheb, U. Akhtar, S. Gonzalez, C. Maldonado, N. Furtado, A. Mohamed, J. Escalante, M. R. Tuttobene, A. Quillen, C. Fontan, E. Albornoz, A. Corso, R. A. Bonomo, G. G. Rao, M. E. Tolmasky, and M. S. Ramirez. (2024). "Insights into Acinetobacter baumannii AMA205's Unprecedented Antibiotic Resistance". International Journal of Molecular Sciences. 25 (21): 1-13. 10.3390/ijms252111424.
DOI: https://doi.org/10.3390/ijms252111424[74] Y. Yao, Q. Chen, and H. Zhou. (2023). "Virulence Factors and Pathogenicity Mechanisms of Acinetobacter baumannii in Respiratory Infectious Diseases". Antibiotics. 12 (12): 1-21. 10.3390/antibiotics12121749.
DOI: https://doi.org/10.3390/antibiotics12121749[75] M. H. Oh, M. Islam, N. Kim, C. H. Choi, M. Shin, and W. S. Shin. (2025). "AbOmpA in Acinetobacter baumannii: Exploring Virulence Mechanisms of Outer Membrane-Integrated and Outer Membrane Vesicle-Associated AbOmpA and Developing Anti-Infective Agents Targeting AbOmpA". Journal of Biomedical Science. 32 : 1-20. 10.1186/s12929-025-01147-5.
DOI: https://doi.org/10.1186/s12929-025-01147-5[76] P. Rafailidis, P. Panagopoulos, C. Koutserimpas, and G. Samonis. (2024). "Current Therapeutic Approaches for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections". Antibiotics. 13 (3): 1-20. 10.3390/antibiotics13030261.
DOI: https://doi.org/10.3390/antibiotics13030261[77] X. Zhang, H. Li, Y. Wang, Y. Kang, and Z. Li. (2023). "Metagenomic Analysis Reveals Antibiotic Resistance Profiles in Tissue Samples from Patients with Diabetic Foot Infections". Journal of Global Antimicrobial Resistance. 34 : 202-210. 10.1016/j.jgar.2023.05.008.
DOI: https://doi.org/10.1016/j.jgar.2023.05.008[78] K. Suryaletha, J. John, M. Periyappilly, R. Sanil, and S. Thomas. (2018). "Metataxonomic Approach to Decipher the Polymicrobial Burden in Diabetic Foot Ulcer and Its Biofilm Mode of Infection". International Wound Journal. 15 (3): 473-481. 10.1111/iwj.12888.
DOI: https://doi.org/10.1111/iwj.12888[79] M. Malone, K. Johani, S. Jensen, I. Gosbell, H. Dickson, H. Hu, and K. Vickery. (2017). "Next Generation DNA Sequencing of Tissues from Infected Diabetic Foot Ulcers". EBioMedicine. 21 : 142-149. 10.1016/j.ebiom.2017.06.026.
DOI: https://doi.org/10.1016/j.ebiom.2017.06.026[80] C. Pouget, C. Dunyach-Remy, A. Pantel, S. Schuldiner, A. Sotto, and J. P. Lavigne. (2020). "Biofilms in Diabetic Foot Ulcers: Significance and Clinical Relevance". Microorganisms. 8 (10): 1-15. 10.3390/microorganisms8101580.
DOI: https://doi.org/10.3390/microorganisms8101580[81] C. Liu, A. J. Ponsero, D. G. Armstrong, B. A. Lipsky, and B. L. Hurwitz. (2020). "The Dynamic Wound Microbiome". BMC Medicine. 18 : 1-12. 10.1186/s12916-020-01820-6.
DOI: https://doi.org/10.1186/s12916-020-01820-6[82] J. Travis, M. Malone, H. Hu, A. Baten, K. Johani, F. Huygens, K. Vickery, and K. Benkendorff. (2020). "The Microbiome of Diabetic Foot Ulcers: A Comparison of Swab and Tissue Biopsy Wound Sampling Techniques Using 16S rRNA Gene Sequencing". BMC Microbiology. 20 : 1-14. 10.1186/s12866-020-01843-2.
DOI: https://doi.org/10.1186/s12866-020-01843-2[83] M. Arman, M. Alinaghizadeh, S. T. Kordi, H. Jahromi, H. Amrulloh, and H. Kioumarsi. (2025). "Investigation of the Anti-Diabetic and Anti-Lipid Peroxidative Properties of Gallic Acid in Diabetic Rats". Journal of Multidisciplinary Applied Natural Science. 5 (1): 32-41. 10.47352/jmans.2774-3047.226.
DOI: https://doi.org/10.47352/jmans.2774-3047.226